High-density chronic neural interfaces
Implanted electrode arrays that record from and stimulate thousands of individual neurons stably for years.
State of the art
Neuralink and Paradromics human trials (2024–2026); speech BCIs decode ~50+ words per minute.
- Tissue response degrades signal over years
- Channel count and wireless bandwidth
Who’s working on it
- Neuralink ↗Startup
Raised $650M Series E in 2025; human trials in the US, Canada, UAE and UK
- Paradromics ↗Startup
FDA IDE in November 2025; first participant achieved real-time speech with the fully implanted Connexus BCI (2026)
- Precision Neuroscience ↗Startup
Surface microelectrode arrays in 50+ patients; 2025 Nature Biomedical Engineering paper on minimally invasive delivery
- SynchronStartup
Raised $200M Series D in November 2025 (total $345M) for the endovascular Stentrode and a next-generation high-channel interface
- David BrandmanResearcherUC Davis Health
Lead PI of Paradromics' Connect-One study and of UC Davis speech-neuroprosthesis work (NEJM 2024)
- BrainGateProgram
Long-running academic consortium whose Utah-array trials established intracortical BCI safety and speech decoding
What to invest in
| Kind | Investment | Scale |
|---|---|---|
| engineering | Biocompatible flexible electrodes with 10k–100k channels | $$$ $100M – $1B |